(Q38250178)

1 September 2017

1 reference

title

Hormonal contraception, thrombosis and age. (English)

1 reference

1 September 2017

1 reference

1 reference

1

Øjvind Lidegaard

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 October 2014

1 reference

Expert Opinion on Drug Safety

1 September 2017

published in

1 reference

1 September 2017

volume

13

1 reference

1 September 2017

issue

10

1 reference

1 September 2017

page(s)

1353-1360

1 reference

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

The differential risk of oral contraceptives: the impact of full exposure history

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Population-based study of risk of venous thromboembolism associated with various oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Oral contraceptives and fatal pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Oral contraceptives and venous thromboembolism: a five-year national case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Hormonal contraception and risk of venous thromboembolism: national follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Hormonal contraception and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Thrombotic stroke and myocardial infarction with hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Contraceptives and cerebral thrombosis: a five-year national case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Oral contraceptives and myocardial infarction: results of the MICA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Low-dose oral contraceptive use and the risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Oral contraceptives and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Effect on stroke of different progestagens in low oestrogen dose oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

Third-generation oral contraceptives and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.950654

10.1517/14740338.2014.950654

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference